- Home
- ALGS vs NXN Comparison
ALGS vs NXN Comparison
Compare ALGS & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- NXN
- Stock Information
- Founded
- ALGS 2018
- NXN 1992
- Country
- ALGS United States
- NXN United States
- Employees
- ALGS N/A
- NXN N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- NXN Trusts Except Educational Religious and Charitable
- Sector
- ALGS Health Care
- NXN Finance
- Exchange
- ALGS Nasdaq
- NXN Nasdaq
- Market Cap
- ALGS 53.0M
- NXN 45.4M
- IPO Year
- ALGS 2020
- NXN N/A
- Fundamental
- Price
- ALGS $9.13
- NXN $11.46
- Analyst Decision
- ALGS Strong Buy
- NXN
- Analyst Count
- ALGS 1
- NXN 0
- Target Price
- ALGS $70.00
- NXN N/A
- AVG Volume (30 Days)
- ALGS 84.2K
- NXN 9.7K
- Earning Date
- ALGS 08-05-2025
- NXN 01-01-0001
- Dividend Yield
- ALGS N/A
- NXN 4.23%
- EPS Growth
- ALGS N/A
- NXN N/A
- EPS
- ALGS N/A
- NXN 0.24
- Revenue
- ALGS $3,270,000.00
- NXN N/A
- Revenue This Year
- ALGS N/A
- NXN N/A
- Revenue Next Year
- ALGS $51.55
- NXN N/A
- P/E Ratio
- ALGS N/A
- NXN $48.42
- Revenue Growth
- ALGS N/A
- NXN N/A
- 52 Week Low
- ALGS $3.76
- NXN $10.64
- 52 Week High
- ALGS $46.80
- NXN $12.45
- Technical
- Relative Strength Index (RSI)
- ALGS 59.79
- NXN 47.13
- Support Level
- ALGS $8.18
- NXN $11.35
- Resistance Level
- ALGS $9.44
- NXN $11.61
- Average True Range (ATR)
- ALGS 0.71
- NXN 0.09
- MACD
- ALGS 0.01
- NXN -0.01
- Stochastic Oscillator
- ALGS 65.95
- NXN 42.31
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.